Streetbeat News

Price Targets

OCUP

Canaccord Genuity analyst John Newman maintains a Buy rating on Ocuphire Pharma (NASDAQ:OCUP) with an $18 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:56 pm

TSM

Susquehanna analyst Mehdi Hosseini maintains a Positive rating on Taiwan Semiconductor (NYSE:TSM) with a $250 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:52 pm

BA

Susquehanna analyst Charles Minervino maintains a Positive rating on Boeing (NYSE:BA) with a $230 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:51 pm

H

Susquehanna analyst Christopher Stathoulopoulos maintains a Neutral rating on Hyatt Hotels (NYSE:H) but lowers the price target from $160 to $150.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:46 pm

FLUT

Susquehanna analyst Joseph Stauff maintains a Positive rating on Flutter Entertainment (NYSE:FLUT) and raises the price target from $222 to $230.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:45 pm

MCRB

Canaccord Genuity analyst John Newman maintains a Buy rating on Seres Therapeutics (NASDAQ:MCRB) and keeps the price target at $10.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:43 pm

LUNR

Cantor Fitzgerald analyst Andres Sheppard has reiterated an Overweight rating on Intuitive Machines (NASDAQ:LUNR) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:41 pm

ACET

Canaccord Genuity analyst John Newman maintains a Buy rating on Adicet Bio (NASDAQ:ACET) with a $19 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:40 pm

OUST

Cantor Fitzgerald analyst Andres Sheppard maintains a Neutral rating on Ouster (NYSE:OUST) and lowers the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:38 pm

INTU

Intuit shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its price target from $750 to $685.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 1:36 pm